ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
BriaCell Therapeutics Corp

BriaCell Therapeutics Corp (BCT)

2.93
-0.08
(-2.66%)
Closed April 27 4:12PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.93
Bid
2.94
Ask
3.10
Volume
1,900
2.91 Day's Range 3.01
2.80 52 Week Range 10.29
Previous Close
3.01
Open
3.01
Last Trade
100
@
2.93
Last Trade Time
Average Volume (3m)
9,502
Financial Volume
-
VWAP
-

BCT Latest News

BriaCell Announces Oral and Poster Presentations at ASCO 2024

Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MDTwo poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and...

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

Preclinical data shows that BriaCell’s Bria-OTS+™ and Bria-PROS+™ effectively induce an anti-cancer immune response via multiple mechanisms including naïve helper and killer T cells, dendritic...

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

PFS of 4.2 months in Phase 2 ADC resistant patients receiving Bria-IMT™ pivotal Phase 3 formulation is twice that of controls in similar studies PFS results reinforced by larger number of prior...

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate cancer), BriaCell’s novel off-the-shelf personalized...

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

PHILADELPHIA and VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

Disease control rate of 61% observed in evaluable Phase 2 patients treated with the same formulation in BriaCell’s pivotal Phase 3 study Disease control rate of 50% in evaluable patients treated...

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

Bria-Pros+ is based on BriaCell’s next generation personalized immunotherapy platformBria-Pros+ is capable of activating multiple types of immune cells, including helper T cells, cytotoxic...

News Brief: BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) a clinical-stage immunotherapy company driven to fight cancer and improve patients’ lives, announced that it has received approval To...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1-3.3003300333.033.192.836263.01095191CS
4-1.05-26.38190954773.984.082.869203.51260159CS
12-2.3-43.97705544935.235.792.895023.82908059CS
26-3.68-55.67322239036.6182.869524.70451737CS
52-6.58-69.19032597279.5110.292.856076.23471435CS
156-7.91-72.970479704810.8415.052.874948.20036107CS
260-7.91-72.970479704810.8415.052.874948.20036107CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
sortagreen sortagreen 3 minutes ago
So a holocaust survivor speaking out against the slaughter of women and children, is like a black person supporting Trump?

Got it.

Israel Israel, uber alles!
RMS555 RMS555 4 minutes ago
Those Short Volume Numbers are not a lie, they are provided by FINRA! KEGS had over 99% Short Volume yesterday......

I will let time tell the truth for the shareholders of KEGS!

Lets Go KEGS! More Good News!

https://www.otcmarkets.com/stock/KEGS/news
KEGS
HulkInvestment HulkInvestment 4 minutes ago
Are you still speaking?
PAOG
backtoreality backtoreality 4 minutes ago
The only time a RS works in otc land is when the Ceo states No RS after stating there will be one.
CGAC
Inquirig Inquirig 5 minutes ago
So, do these results prove activity of DCVax-L in glioblastoma? The answer to this question is clearly: no, they do not. Indeed, there is a trend towards the recognition of the validity of external controls for comparison, but it really requires a near total similarity between trials or datasets—fro
NWBO
glenn1919 glenn1919 5 minutes ago
CUTR.................................https://stockcharts.com/h-sc/ui?s=CUTR&p=W&b=5&g=0&id=p86431144783
CUTR
Duma Duma 5 minutes ago
Good week to be on (mostly on) the sidelines.

It was a terrible week for me. After QQQ made basically a 6 day run to the bottom, on Monday we got a turnaround green bar. From the close on Monday to Friday's, QQQ was up 2.9%. That is a lot of gain to let go by with out doing anything.
QQQ
Truth and Transparency Truth and Transparency 6 minutes ago
You're pathetic
NB
zandant zandant 6 minutes ago
So why isn't Ehrlich, the CEO of this mess, blowing the Brilacidin horn in the same manner? Million dollar negative judgements, no cash, no board, no communication, no press releases in almost a year, not even on the Pink Sheets anymore, having fallen into this Expert quagmire. You keep posting thi
IPIX
RMS555 RMS555 6 minutes ago
Recent Facts of KEGS: KEGS has verifiable assets, 4 properties in New York.
KEGS is now delivering beer to 45 states plus DC.
KEGS has a new distributor in Jefferson County, New York.
KEGS beer is available to purchase in Canada.
KEGS 1812 beer has won multiple awar
KEGS
glenn1919 glenn1919 7 minutes ago
INVZ....................................https://stockcharts.com/h-sc/ui?s=INVZ&p=W&b=5&g=0&id=p86431144783
INVZ
Moonboy1 Moonboy1 7 minutes ago
I wonder how much Black rock paid Jerome Powell to keep interest rates high.
BTCUSD
Signor Signor 8 minutes ago
New owner not in the medical field
RNVA
StayHumble StayHumble 8 minutes ago
✅♻Why$DBMM🔥GroundfloorInvestment🔥$GME|$AMC Level
$DBMM @dbmm_group
Positioned to disrupt multitrillion-dollar global market
Ground-floor investment opportunity
Comparisons to $GME and $AMC https://twitter.com/dbmm_group/status/1687
AMC DBMM GME
glenn1919 glenn1919 10 minutes ago
TUP...................https://stockcharts.com/h-sc/ui?s=TUP&p=W&b=5&g=0&id=p86431144783
TUP
USAlonewolf USAlonewolf 11 minutes ago
Never argue with a fool, onlookers may not be able to tell the difference.

I know I cant
NB
Golden Cross Golden Cross 12 minutes ago
$AGBA Key Players In The Video-Sharing Social Network Industry

AGBA/Triller Merger Play!

https://investorshub.advfn.com/uimage/uploads/2024/4/27/rbdcakeyplayers.png
AGBA
trunkmonk trunkmonk 12 minutes ago
BTC ETFs cooling, although that should not matter according to all the crypto experts, halving is everything. of course its never before and soft right after, halving affect has not really begun yet. China buying gold at record pace, its people and gov.

https://www.gold.org/goldhub/g
BTCUSD
Truth and Transparency Truth and Transparency 13 minutes ago
Your ignorance is obvious. The share price is a reflection of Mark’s incompetence and nothing less. FYI, there’s not a single reported fatality in Nebraska from the tornados. You’re spreading lies and disinformation as usual. So pathetic
NB
glenn1919 glenn1919 14 minutes ago
BLNK..................................https://stockcharts.com/h-sc/ui?s=BLNK&p=W&b=5&g=0&id=p86431144783
BLNK

Your Recent History

Delayed Upgrade Clock